Jiangfeng Du

Jiangfeng Du

Auto-generated profile, based on publicly available information

Jiangfeng Du

Department of Medical Imaging, First Hospital of Shanxi Medical University, Taiyuan, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2025 in Advanced Science
Verified
Journal Article
Open access
XHXiaoniu He
Xiaoniu He
YLYuanpei Li
Yuanpei Li
JLJian Li
Jian Li
YLYu Li
Yu Li
SCSijie Chen
Sijie Chen
QMQi Mei
Qi Mei
The current treatment of triple‐negative breast cancer (TNBC) is still primarily based on platinum‐based chemotherapy. However, TNBC cells frequently develop resistance to platinum and experience relapse after drug withdrawal. It is crucial to specifically target and eliminate cisplatin‐tolerant cells after platinum administration. Here, it is reported that upregulated N 6 ‐methyladenosine (m 6 A) modification drives the development of resistance in TNBC cells during cisplatin treatment. Mechanistically, histone deacetylase 2 (HDAC2) mediates delactylation of methyltransferase‐like 3 (METTL3), facilitating METTL3 interaction with Wilms’‐tumor‐1‐associated protein and subsequently increasing m 6 A of transcript‐associated DNA damage repair. This ultimately promotes cell survival under cisplatin. Furthermore, pharmacological inhibition of HDAC2 using Tucidinostat can enhance the sensitivity of TNBC cells to cisplatin therapy. This study not only elucidates the biological function of lactylated METTL3 in tumor cells but also highlights its negative regulatory effect on cisplatin resistance. Additionally, it underscores the nonclassical functional mechanism of Tucidinostat as a HDAC inhibitor for improving the efficacy of cisplatin against TNBC.

3 February 2022 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
RLRuixue Liu
Ruixue Liu
LGLinji Gong
Linji Gong
XZXianyu Zhu
Xianyu Zhu
SZShuang Zhu
Shuang Zhu
XWXiaochen Wu
Xiaochen Wu
Zhanjun GuZhanjun Gu
Zhanjun Gu

30 October 2023 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
QDQingrong Dong
Qingrong Dong
TXTingyu Xue
Tingyu Xue
HYHaili Yan
Haili Yan
FLFang Liu
Fang Liu
RLRuixue Liu
Ruixue Liu
HZHui Zhang
Hui Zhang
Radiotherapy (RT) plays an important role in tumor therapy due to its noninvasiveness and wide adaptation. In recent years, radiation therapy has been discovered to induce an anti-tumor immune response, which arouses widespread concern among scientists and clinicians. In this review, we highlight recent advances in the applications of nano-biomaterials for radiotherapy-activated immunotherapy. We first discuss the combination of different radiosensitizing nano-biomaterials and immune checkpoint inhibitors to enhance tumor immune response and improve radiotherapy efficacy. Subsequently, various nano-biomaterials-enabled tumor oxygenation strategies are introduced to alleviate the hypoxic tumor environment and amplify the immunomodulatory effect. With the aid of nano-vaccines and adjuvants, radiotherapy refreshes the host's immune system. Additionally, ionizing radiation responsive nano-biomaterials raise innate immunity-mediated anti-tumor immunity. At last, we summarize the rapid development of immune modulatable nano-biomaterials and discuss the key challenge in the development of nano-biomaterials for tumor radio-immunotherapy. Understanding the nano-biomaterials-assisted radio-immunotherapy will maximize the benefits of clinical radiotherapy and immunotherapy and facilitate the development of new combinational therapy modality. Graphical Abstract

25 October 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
YYYitong Yuan
Yitong Yuan
MXMiaomiao Xu
Miaomiao Xu
LFLimin Feng
Limin Feng
WZWanting Zhong
Wanting Zhong
LZLongzhu Zhang
Longzhu Zhang
JDJiangfeng Du
Jiangfeng Du

21 September 2023 in Nano Today
Verified
Journal Article
Closed access
RLRuixue Liu
Ruixue Liu
RWRonghua Wang
Ronghua Wang
MZMaoru Zhao
Maoru Zhao
YLYaping Liu
Yaping Liu
XZXianyu Zhu
Xianyu Zhu
JDJiangfeng Du
Jiangfeng Du

1 December 2021 in Nano Today
Verified
Journal Article
Closed access
LGLong Gao
Long Gao
HYHaili Yan
Haili Yan
SZShuang Zhu
Shuang Zhu
XWXiaochun Wang
Xiaochun Wang
YTYan Tan
Yan Tan
ZGZhanjun Gu
Zhanjun Gu